Key result
Suspected active vasculitis linked to ~2.5-fold higher vascular uptake on [11C]-PK11195 PET/CT.
Why the study?
Activated macrophages and T lymphocytes play a key role in large-vessel vasculitides, but noninvasive imaging methods for vascular inflammation are needed.
Does positron emission tomography with [11C]-PK11195 and CT angiography identify vascular inflammation in symptomatic patients with clinical suspicion of active vasculitis compared to asymptomatic controls?
Observational (n=15)
Does positron emission tomography with [11C]-PK11195 and CT angiography identify vascular inflammation in symptomatic patients with clinical suspicion of active vasculitis compared to asymptomatic controls?
Answers are grounded in this paper and cite their sources.
[11C]-PK11195 PET/CT angiography enables noninvasive imaging of vascular inflammation by binding to activated macrophages, identifying active vasculitis even when serum biomarkers are not significantly elevated.
OBJECTIVES: We sought to investigate whether positron emission tomography/computed tomography (CT) angiography using [11C]-PK11195, a selective ligand for peripheral benzodiazepine receptors expressed in activated macrophages, can be used to image vascular inflammation. BACKGROUND: Activated macrophages and T lymphocytes are fundamental elements in the pathogenesis of large-vessel vasculitides. METHODS: Fifteen patients (age 52+/-16 years) with systemic inflammatory disorders (6 consecutive symptomatic patients with clinical suspicion of active vasculitis and 9 asymptomatic control patients) underwent positron emission tomography with [11C]-PK11195 and CT angiography. [11C]-PK11195 uptake was measured by calculating target-to-background ratios of activity normalized to venous blood. RESULTS: Coregistration of positron emission tomography with contrast-enhanced CT angiography facilitated localization of [11C]-PK11195 arterial wall uptake. Visual analysis revealed focal [11C]-PK11195 uptake in the arterial wall of all 6 symptomatic patients, but in none of the asymptomatic controls. Although serum inflammatory biomarkers (C-reactive protein, erythrocyte sedimentation rate, white cell count) did not differ significantly between the 2 groups, symptomatic patients had increased [11C]-PK11195 vascular uptake (target-to-background ratio 2.41+/-1.59 vs. 0.98+/-0.10; p=0.001). CONCLUSIONS: By binding to activated macrophages in the vessel wall, [11C]-PK11195 enables noninvasive imaging of vascular inflammation. Alternative longer-lived radioligands for probing peripheral benzodiazepine receptors are being tested for wider clinical applications.
No takes yet. Share an insight, caveat, or question.
Pugliese et al. (2010) conducted an observational in Systemic inflammatory disorders / Vasculitis (n=15). Clinical suspicion of active vasculitis vs. Asymptomatic controls was evaluated on [11C]-PK11195 vascular uptake (target-to-background ratio) (p=0.001). Patients with suspected active vasculitis had increased [11C]-PK11195 vascular uptake on PET/CT compared to asymptomatic controls.
Synapse has enriched 10 related papers. Consider them for comparative context: